Heteroresistance Mechanisms in Pathogenic Bacteria

Heteroresistance describes a phenomenon in which a minor subpopulation of bacterial cells exhibits significantly higher antibiotic resistance than the dominant, susceptible population. This transient and often unstable resistance arises through diverse genetic and physiological processes, including amplification of resistance determinants, fluctuations in plasmid copy number, transposition of resistance genes onto cryptic elements and regulatory changes mediated by small RNAs or two-component systems. These mechanisms generally impose a fitness cost in the absence of antibiotic pressure, leading to rapid reversion to susceptibility, yet they can drive treatment failure when resistant subpopulations expand under drug exposure. Heteroresistance has been documented across Gram-negative pathogens such as Klebsiella pneumoniae, Escherichia coli and Acinetobacter baumannii. Its global significance lies in its capacity to evade routine susceptibility testing, complicate therapeutic decision-making and fuel persistent or recurrent infections. Practical strategies to mitigate its impact include improved diagnostics to detect subpopulations, the design of combination regimens that circumvent multiple resistance phenotypes and the development of inhibitors targeting key amplification or regulatory pathways.

Research from Nature Portfolio

Recent studies have elucidated three concurrent drivers of gene-dosage-dependent heteroresistance in a multidrug-resistant Klebsiella pneumoniae isolate. Tandem chromosomal amplifications, elevated plasmid copy number and transposition of resistance cassettes onto cryptic plasmids were each shown to confer heteroresistance to multiple antibiotic classes. These genetic alterations proved unstable, imposing a burden on bacterial fitness and reverting rapidly once antibiotics were withdrawn. Crucially, a murine gut colonisation model demonstrated that transient amplification-driven heteroresistance can cause in vivo treatment failure. Bioinformatic surveys further revealed that these three mechanisms are widespread among Escherichia coli bloodstream isolates, underscoring the need for therapeutic approaches that address the dynamic interplay between chromosomes, plasmids and mobile elements.

Heteroresistance Mechanisms in Pathogenic Bacteria publication trend

The graph below shows the total number of articles in heteroresistance mechanisms in pathogenic bacteria across all publications each year (not limited to Nature Index journals).

Technical terms

Heteroresistance: Presence of a minor resistant subpopulation within a largely susceptible bacterial culture.

Population analysis profiling (PAP): Quantitative method to detect and measure resistant subpopulations across antibiotic gradients.

Tandem amplification: Repeated duplication of a chromosomal segment containing resistance genes, increasing gene dosage.

Transposition: Movement of genetic elements (transposons) carrying resistance determinants between DNA molecules.

Two-component system: Signal transduction module comprising a sensor kinase and response regulator that modulates gene expression in response to environmental stimuli.

Minimal inhibitory concentration (MIC): Lowest antibiotic concentration that prevents visible bacterial growth in vitro.

References

1. Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance. Nature Communications (2024).
2. Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study. The Lancet Microbe (2025).
3. Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment. Journal of Biomedical Science (2023).
4. A novel small RNA PhaS contributes to polymyxin B-heteroresistance in carbapenem-resistant Klebsiella pneumoniae. Emerging Microbes & Infections (2024).